Table 3.
Freedom from peripheral arterial revascularization in statin‐treated patients with high cardiovascular risk and high triglycerides vs comparators (Kaplan‐Meier analysis)
Cohort | 0.5 Year | 1 Year | 2 Years | 3 Years | 4 Years | 5 Years | Clustered P‐value |
---|---|---|---|---|---|---|---|
High triglyceridesa | 0.9855 (1 0790) | 0.9760 (9097) | 0.9611 (6920) | 0.9496 (5523) | 0.9397 (3776) | 0.9272 (2895) | <.001 |
Comparatorb | 0.9921 (1 0865) | 0.9861 (9242) | 0.9757 (7117) | 0.9660 (5769) | 0.9578 (3975) | 0.9523 (3104) |
Values represent probability of freedom from peripheral arterial revascularization (number of patients at risk). Clustered P‐value was calculated using Cox proportional hazard model with cohort as independent variable.
High triglycerides cohort: triglycerides 200‐499 mg/dL.
Comparator cohort: triglycerides <150 mg/dL and high‐density lipoprotein cholesterol >40 mg/dL.